Effectiveness of Synbiotic and Vitamin D in Atopic Dermatitis

Phase 3

• Conditions: Atopic Dermatitis.; Atopic dermatitisExcl.:circumscribed neurodermatitis (L28.0)L20.0Besnier prurigoL20.8Other atopic dermatitisEczema:flexural NECinfantile (acute)(chronic)intrinsic (allergic)Neurodermatitis:atopicdiffuseL20.9Atopic dermatitis, unspecifiedL21; L20-L30

• Registration Number: IRCT20180626040248N1
• Lead Sponsor: Sabzevar University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 October 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Being 1-24 month of age
Absence of any other chronic disease
Having used no immunosuppressive medicines, corticosteroids and antibiotics for one week prior of the study
Mother's willingness

Exclusion Criteria

Infectious disease
Receive immunosuppressive medicines, corticosteroids and antibiotics
Mother's unwillingness

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score of Atopic Dermatitis according to SCORAD. Timepoint: Beginning and end of the study (week 8). Method of measurement: SCORAD (scoring of Atopic Dermatitis).